|
Clinical Information
|
patient
|
XJ204821 |
|
Age
|
65 |
|
Gender
|
F |
|
Genotype
|
HBV_gtC |
|
Diagnosis
|
hepatocellular carcinoma |
|
HBV DNA
|
220IU/ml |
|
HBeAg
|
0 |
|
AFP(ng/ml)
|
>1210 |
|
PLT(log IU/mL)
|
149 |
|
HBcAb
|
1 |
|
HBsAb
|
0 |
|
HBeAb
|
0 |
|
HBsAg
|
1 |
|
ctDNA concentration
|
0.3334 |
|
marker
|
ctDNA+ |
|
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
|
HBsAg (IU/ml)
|
>250 |
|
BCLC
|
B |
|
ACJJ
|
I |
|
Tumor maximum size
|
12 |
|
Tumor count
|
1 |
|
MVI
|
M0 |
|
AFP-L3
|
38.2 |
|
PIVKA-II (mAU/ml)
|
1916 |
|
CA199 (U/ml)
|
13.7 |
|
Cirrhosis history
|
0 |
|
Fatty liver
|
0 |
|
Hepatic encephalopathy (1-3)
|
1 |
|
Ascites (1-3)
|
1 |
|
TBIL (μmol/L)
|
1 |
|
ALB (g/L)
|
1 |
|
INR
|
1 |
|
HBV integration detection
|
Yes |
|
Integration number
|
29 |
|
HBV subtype frequency
|
0.995816929 |
|
|
Virus Dataset Sample Detail